The VaPURE™ technology MoldCure uses has been studied by the U.S. Army Corps of Engineers and tested in independent GLP-compliant laboratories. Below are the three papers that underpin the work we do in your home — with links to each PDF.
Three independent works document the technology MoldCure deploys: a multi-month field test by the U.S. Army Corps of Engineers, a compilation of GLP-compliant independent laboratory efficacy reports, and a technical white paper explaining why the vapor behaves like a gas. Skip ahead, or read each in order below.
A six-month evaluation by the Army's Engineer Research and Development Center of the VaPURE™ application system on two buildings at Fort Campbell, Kentucky — measuring both initial efficacy and long-term recurrence.
The U.S. Army needed a way to remediate mold in its buildings without removing structural materials. The Engineer Research and Development Center treated two mold-affected buildings at Fort Campbell — a dining facility and a barracks administration building — and compared spore counts before treatment, immediately after, and across the months that followed.
The headline result — a sustained 95%+ reduction in spore counts at the six-month mark — is what makes this study load-bearing. Day-one efficacy is common across mold treatments; verified durability is rare. The fact that those reductions held over half a year, without retreatment, is the part of the report that does the most work.
The full ERDC technical report is hosted publicly by the U.S. Army Corps of Engineers digital library.
A compiled set of GLP-compliant independent laboratory tests of the vapor peracetic acid (VPA) treatment against mold, bacteria, and viral targets — the underlying chemistry behind the MoldCure VaPURE™ process.
"Good Laboratory Practice" is the methodological standard regulators apply to safety and efficacy studies — the same rigour used to evaluate pharmaceuticals. This compilation aggregates a series of independent GLP-compliant lab tests of vapor peracetic acid (VPA), the chemistry that powers the VaPURE™ treatment we deploy in your home.
The headline finding is a Log-6+ reduction — more than a 99.9999% kill — against the panel of mold, bacterial, and viral targets tested. Log-6 is the threshold a treatment must hit to be classified as a true sterilant. Most consumer disinfectants stop at Log-3 (99.9%); VaPURE™'s underlying chemistry clears the bar three orders of magnitude higher.
The compilation is hosted publicly and includes the methodology, organisms tested, and individual lab reports.
A technical explainer of the three "magic-bullet" variables — 7.5μm particle size, vapor phase change, and dwell time — that make the treatment behave like a gas and reach where surface cleaning never does.
This paper breaks down the physics of why VaPURE™ outperforms conventional remediation. Three variables, working together, are what make the treatment behave like a gas rather than a liquid: particle size, phase change, and dwell time.
Particle size. At 7.5μm, each vapor droplet is roughly 1/9th the diameter of a human hair — small enough to suspend in air and travel anywhere air goes: wall cavities, ductwork, behind cabinets, into porous building materials.
Phase change. The treatment is delivered as a liquid that flashes to vapor on application, occupying the full air volume of the structure rather than coating only the surfaces a sprayer can hit.
Dwell time. The vapor remains in suspension long enough to denature mold proteins on contact — eradicating the spore rather than just dislodging it.
Together, these explain how a single in-place treatment can reach the 90% of the home where mold actually lives and where scrub-and-cut crews can only reach by tearing structural materials out.
Reach out to our team to schedule a consultation.